Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
Cyclic AMP-Dependent Protein Kinases
Cyclic AMP
Protein Kinases
Protein Kinase C
An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters.
Phosphorylation
Calcium-Calmodulin-Dependent Protein Kinases
A CALMODULIN-dependent enzyme that catalyzes the phosphorylation of proteins. This enzyme is also sometimes dependent on CALCIUM. A wide range of proteins can act as acceptor, including VIMENTIN; SYNAPSINS; GLYCOGEN SYNTHASE; MYOSIN LIGHT CHAINS; and the MICROTUBULE-ASSOCIATED PROTEINS. (From Enzyme Nomenclature, 1992, p277)
Enzyme Activation
Calcium-Calmodulin-Dependent Protein Kinase Type 2
A multifunctional calcium-calmodulin-dependent protein kinase subtype that occurs as an oligomeric protein comprised of twelve subunits. It differs from other enzyme subtypes in that it lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE.
Calcium-Calmodulin-Dependent Protein Kinase Type 1
Calcium
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
Cyclic AMP-Dependent Protein Kinase Type II
Protein-Serine-Threonine Kinases
Cyclic GMP-Dependent Protein Kinases
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Signal Transduction
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Amino Acid Sequence
Calmodulin
A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels.
Isoenzymes
Mitogen-Activated Protein Kinases
A superfamily of PROTEIN-SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).
MAP Kinase Signaling System
An intracellular signaling system involving the MAP kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade.
Phosphatidylinositol 3-Kinases
Phosphotransferases that catalyzes the conversion of 1-phosphatidylinositol to 1-phosphatidylinositol 3-phosphate. Many members of this enzyme class are involved in RECEPTOR MEDIATED SIGNAL TRANSDUCTION and regulation of vesicular transport with the cell. Phosphatidylinositol 3-Kinases have been classified both according to their substrate specificity and their mode of action within the cell.
Cells, Cultured
p38 Mitogen-Activated Protein Kinases
A mitogen-activated protein kinase subfamily that regulates a variety of cellular processes including CELL GROWTH PROCESSES; CELL DIFFERENTIATION; APOPTOSIS; and cellular responses to INFLAMMATION. The P38 MAP kinases are regulated by CYTOKINE RECEPTORS and can be activated in response to bacterial pathogens.
Protein Binding
Enzyme Inhibitors
eIF-2 Kinase
A dsRNA-activated cAMP-independent protein serine/threonine kinase that is induced by interferon. In the presence of dsRNA and ATP, the kinase autophosphorylates on several serine and threonine residues. The phosphorylated enzyme catalyzes the phosphorylation of the alpha subunit of EUKARYOTIC INITIATION FACTOR-2, leading to the inhibition of protein synthesis.
Cyclic GMP
Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed)
Tetradecanoylphorbol Acetate
Base Sequence
Protein Kinase C-alpha
Mutation
Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. (1/164)
The primary element in the cAMP signal transduction pathway is the cAMP-dependent protein kinase (PKA). Expression of the RIalpha subunit of type I PKA is elevated in a variety of human tumours and cancer cell lines. The purpose of this study was to assess the prognostic importance of RIalpha expression in patients with ovarian cancer. We have evaluated the expression of RIalpha in a panel of human ovarian tumours (n = 40) and five human ovarian cancer cell lines using quantitative reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis. The human ovarian cell lines OAW42 and OTN14 express high endogenous levels of RIalpha mRNA and protein (at significantly higher mRNA levels than high tissue expressors, P < 0.05). The ovarian cell line A2780 expresses low endogenous levels of RIalpha mRNA and protein (also at higher mRNA levels than low tissue expressors, P < 0.05). Quantitative RT-PCR revealed no significant difference in RIalpha mRNA expression between different ovarian histological subtypes in this study. No associations were found between RIalpha mRNA expression and differentiation state. RIalpha mRNA expression was significantly associated with tumour stage (P = 0.0036), and this remained significant in univariate analysis (P = 0.0002). A trend emerged between RIalpha mRNA expression levels and overall survival in univariate analysis (P = 0.051), however, by multivariate analysis, stage remained the major determinant of overall survival (P = 0.0001). This study indicates that in ovarian epithelial tumours high RIalpha mRNA expression is associated with advanced stage disease. RIalpha expression may be of predictive value in ovarian cancer and may be associated with dysfunctional signalling pathways in this cancer type. (+info)Diminished levels of protein kinase A RI alpha and RI beta transcripts and proteins in systemic lupus erythematosus T lymphocytes. (2/164)
Deficient type I protein kinase A phosphotransferase activity occurs in the T cells of 80% of subjects with systemic lupus erythematosus (SLE). To investigate the mechanism of this deficient isozyme activity, we hypothesized that reduced amounts of type I regulatory (RI) isoform transcripts, RIalpha and RIbeta, may be associated with a diminution of RIalpha and/or RIbeta protein. Sixteen SLE subjects with a mean (+/-1 SD) SLE disease activity index of 12.4 +/- 7.2 were studied. Controls included 16 normal subjects, six subjects with primary Sjogren's syndrome (SS), and three subjects with SS/SLE overlap. RT-PCR revealed that normal, SS, SS/SLE, and SLE T cells expressed mRNAs for all seven R and catalytic (C) subunit isoforms. Quantification of mRNAs by competitive PCR revealed that the ratio of RIalpha mRNA to RIbeta mRNA in normal T cells was 3.4:1. In SLE T cells there were 20 and 49% decreases in RIalpha and RIbeta mRNAs (RIbeta; p = 0.008), respectively, resulting in an RIalpha:RIbeta mRNA of 5.3:1. SS/SLE T cells showed a 72.5% decrease in RIbeta mRNA compared with normal controls (p = 0.01). Immunoblotting of normal T cell RIalpha and RIbeta proteins revealed a ratio of RIalpha:RIbeta of 3.2:1. In SLE T cells, there was a 30% decrease in RIalpha protein (p = 0.002) and a 65% decrease in RIbeta protein (p < 0.001), shifting the ratio of RIalpha:RIbeta protein to 6.5:1. T cells from 25% of SLE subjects lacked any detectable RIbeta protein. Analysis of several lupus T cell lines demonstrated a persistent deficiency of both proteins, excluding a potential effect of disease activity. In conclusion, reduced expression of RIalpha and RIbeta transcripts is associated with a decrement in RIalpha and RIbeta proteins and may contribute to deficient type I protein kinase A isozyme activity in SLE T cells. (+info)Structural characterization of the membrane-associated regulatory subunit of type I cAMP-dependent protein kinase by mass spectrometry: identification of Ser81 as the in vivo phosphorylation site of RIalpha. (3/164)
The mechanism by which the type Ialpha regulatory subunit (RIalpha) of cAMP-dependent protein kinase is localized to cell membranes is unknown. To determine if structural modification of RIalpha is important for membrane association, both beef skeletal muscle cytosolic RI and beef heart membrane-associated RI were characterized by electrospray ionization mass spectrometry. Total sequence coverage was 98% for both the membrane-associated and cytosolic forms of RI after digestion with AspN protease or trypsin. Sequence data indicated that membrane-associated and cytosolic forms of RI were the same RIalpha gene product. A single RIalpha phosphorylation site was identified at Ser81 located near the autoinhibitory domain of both membrane-associated and cytosolic RIalpha. Because both R subunit preparations were 30-40% phosphorylated, this post-translational modification could not be responsible for the membrane compartmentation of the majority of RIalpha. Mass spectrometry also indicated that membrane-associated RIalpha had a higher extent of disulfide bond formation in the amino-terminal dimerization domain. No other structural differences between cytosolic and membrane-associated RIalpha were detected. Consistent with these data, masses of the intact proteins were identical by LCQ mass spectrometry. Lack of detectable structural differences between membrane-associated and cytosolic RIalpha strongly suggests an interaction between RIalpha and anchoring proteins or membrane lipids as more likely mechanisms for explaining RIalpha membrane association in the heart. (+info)Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway. (4/164)
Expression of the RIalpha subunit of cAMP-dependent protein kinase type I is increased in human cancers in which an autocrine pathway for epidermal growth factor-related growth factors is activated. We have investigated the effect of sequence-specific inhibition of RIalpha gene expression on ovarian cancer cell growth. We report that RIalpha antisense treatment results in a reduction in RIalpha expression and protein kinase A type I, and inhibition of cell growth. The growth inhibition was accompanied by changes in cell morphology and appearance of apoptotic nuclei. In addition, EGF receptor, c-erbB-2 and c-erbB-3 levels were reduced, and the basal and EGF-stimulated mitogen-activated protein kinase activities were reduced. Protein kinase A type I and EGF receptor levels were also reduced in cells overexpressing EGF receptor antisense cDNA. These results suggest that the antisense depletion of RIalpha leads to blockade of both the serine-threonine kinase and the tyrosine kinase signaling pathways resulting in arrest of ovarian cancer cell growth. (+info)Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. (5/164)
Overexpression of the RIalpha subunit of cAMP-dependent protein kinase (PKA) has been demonstrated in various human cancers. PKA has been suggested as a potential target for cancer therapy. The goal of the present study was to evaluate an anti-PKA antisense oligonucleotide (mixed-backbone oligonucleotide) as a therapeutic approach to human cancer treatment. The identified oligonucleotide inhibited the growth of cell lines of human colon cancer (LS174T, DLD-1), leukemia (HL-60), breast cancer (MCF-7, MDA-MB-468), and lung cancer (A549) in a time-, concentration-, and sequence-dependent manner. In a dose-dependent manner, the oligonucleotide displayed in vivo antitumor activity in severe combined immunodeficient and nude mice bearing xenografts of human cancers of the colon (LS174T), breast (MDA-MB-468), and lung (A549). The routes of drug administration were intraperitoneal and oral. Synergistic effects were found when the antisense oligonucleotide was used in combination with the cancer chemotherapeutic agent cisplatin. The pharmacokinetics of the oligonucleotide after oral administration of (35)S-labeled oligonucleotide into tumor-bearing mice indicated an accumulation and retention of the oligonucleotide in tumor tissue. This study further provides a basis for clinical studies of the antisense oligonucleotide targeted to the RIalpha subunit of PKA (GEM 231) as a cancer therapeutic agent used alone or in combination with conventional chemotherapy. (+info)A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors. (6/164)
GEM231 is a mixed-backbone oligonucleotide targeting the regulatory subunit alpha of type I protein kinase A, which plays an important role in growth and maintenance of malignancies. Preclinically, GEM231 inhibited human cancer xenografts either alone or synergistically with chemotherapeutic agents and has demonstrated an improved metabolic stability and safety profile compared to the first-generation compounds. Objectives of this study were to define the safety profile and pharmacokinetics of GEM231 administered as 2-h IV infusions twice weekly in patients with refractory solid tumors. Fourteen patients (13 evaluable for safety) received escalating doses of GEM231 at 20-360 mg/m2 (2.5-9 mg/kg). Tumor histologies included non-small cell lung cancer, renal cell cancer, sarcoma, and others. The plasma pharmacokinetics of GEM231 were linear and predictable. Maximum plasma concentration (Cmax) reached 50-70 microg/ml (8-13 microM) at dose 360 mg/m2 and 27-32 microg/ml at dose 240 mg/m2. The plasma half-life was about 1.5 h. The only clinical toxicities were transient grade I-II fever and fatigue at doses > or = 240 mg/m2. There was no treatment-related complement activation or thrombocytopenia at any dose level, except with the first dose in one patient who had pre-existing borderline thrombocytopenia. Transient activated partial thrombin time prolongation occurred at doses > or =160 mg/m2. Dose-limiting toxicities included transient activated partial thrombin time prolongation (one of three patients at 360 mg/m2) and cumulative reversible transaminase elevation (three of three patients at 360 mg/m2 and three of six patients at 240 mg/m2 during weeks 3-10). One patient with colon cancer had stabilization of a previously rising carcinoembryonic antigen. Thus, in this first clinical evaluation of a mixed-backbone oligonucleotide in cancer patients, high plasma concentrations of GEM231 were well tolerated without significant acute toxicities, but prolonged treatment was associated with reversible transaminitis. Although 240 mg/m2 by 2-h infusion twice weekly was safe for a 4-week treatment duration, alternative dosing schedules are being tested to minimize the cumulative toxicity, which will be essential to extend the duration of therapy at the highest GEM231 dose tested. (+info)8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. (7/164)
OBJECTIVES: The aims of the present study were to assess 1) the effect of 8-C1-cAMP (cyclic-3'-5'-adenosine monophosphate) on vascular smooth muscle cell (VSMC) proliferation in vitro and 2) the efficacy of systemic administration of 8-C1-cAMP on neointimal formation after balloon injury in vivo. BACKGROUND: Neointimal formation after vascular injury is responsible for restenosis after arterial stenting. Recently, 8-C1-cAMP, a cAMP analogue that induces growth arrest, has been safely administered in phase I studies in humans. METHODS: The effect of 8-C1-cAMP on cell proliferation was first assessed on SMCs in vitro. To study the effects of cAMP in vivo, balloon injury was performed in 67 rats using a 2F Fogarty balloon catheter. RESULTS: The 8-C1-cAMP markedly inhibited VSMC proliferation in vitro, reduced protein kinase A (PKA) RIalpha subunit expression, and induced PKA RIIbeta subunit expression. In addition, 8-C1-cAMP reduced, in a dose-dependent manner, neointimal area and neointima/media ratio after balloon injury. The proliferative activity, assessed by proliferating nuclear cell antigen immunostaining, revealed a reduction of proliferative activity of VSMCs in vivo in the 8-C1-cAMP group. Moreover, the systemic administration of 8-C1-cAMP did not affect renal function, blood pressure and heart rate. CONCLUSIONS: We conclude that 8-C1-cAMP potently inhibits VSMC proliferation in vitro and reduces neointima formation by balloon injury in vivo after systemic administration. These data may have a clinical relevance in designing future strategies to prevent restenosis after arterial stenting and perhaps after percutaneous transluminal coronary angioplasty. (+info)Alternative 5'-exons of the mouse cAMP-dependent protein kinase subunit RIalpha gene are conserved and expressed in both a ubiquitous and tissue-restricted fashion. (8/164)
The activity of cAMP-dependent protein kinase is controlled by its regulatory subunits. Mouse RIalpha regulatory subunit expression is initiated from five different non-coding 5'-regions (exons 1a, 1b, 1c, 1d and 1e). This organization appears to be conserved among species. All mouse tissues accumulate exon 1a and 1b transcripts and most contain more 1b than 1a, except brain, heart and oesophagus. Exon 1d and 1e transcripts are found in several tissues, while exon 1c is testis-specific. All five transcripts are in RIalpha-rich tissues: gonads and adrenal glands. (+info)
Pełny tekst: Zespół Cushinga z powodu pierwotnej pigmentowej choroby guzkowej nadnerczy u dwóch
braci z zespołem Carneya,...
PRKAR2A ENST00000296446 Gene - Somatic Mutations in Cancer
Addgene: pDONR223-PRKAR1B
With Their High Precision CNC Machining Service, Runsom Precision Co.,Ltd Announces a Fast Delivery of CNC Machining Parts for...
CNC Synergies
EDGE Pro Ti CNC system | Hypertherm
Primary pigmented nodular adrenocortical disease presenting with a unilateral adrenocortical nodule treated with bilateral...
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney...
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney...
Browse In Adolescent/young adult, Female, Hirsutism, Hormone | EDM Case Reports
Browse In Necrosis | EDM Case Reports
Browse | erc
Human PRKAR1A ELISA Kit | biobool.com
Antisense protein of HTLV-2 (APH-2) associates with PML nuclear bodies: molecular determinants and functional implications |...
Expression of PRKAR2B in ovarian cancer - The Human Protein Atlas
Mineola High School : CNC Routers - CNC Plasma Cutters - Used and New CNC Routers Mineola High School
BIOPHYSICS SEMINAR Featuring Giuseppe Melacini Tapping the Translation Potential of cAMP-Signalling and Amyloid Inhibition...
Angry Gun CNC Adjustable Competitive Trigger Box for WE M4 GBB ( Black Trigger )
Carney complex
Operative management of Cushing Syndrome secondary to micronodular adrenal hyperplasia<...
Unravelling the mystery in a case of persistent ACTH-independent Cushings syndrome | [email protected]
PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney...
Adrenocortical Disease in Ferrets | Cascade Kennels
Plus it
PRKAR1B purified MaxPab rabbit polyclonal antibody (D01P) - (H00005575-D01P) - Products - Abnova
Reactome | cAMP:PKA regulatory subunit [cytosol]
Health Article - Acrodysostosis - AARP
PIK3C2B (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta)
Bacterial Recombination - BACTERIAL RECOMBINATION Purposes A Vaccine production(subunit type B Production of proteins(growth...
WikiGenes - prkar1ab - protein kinase, cAMP-dependent, regulatory...
DGIdb - PRKAR2A Gene Record
Cnc Machining Services China | Cnc Turning
rotary cnc wood router multi use cnc router with compact structure
Gantry Style CNC from plywood | OpenBuilds
Homemade Cnc Lathe
DMS announces Renishaw probing integration on Fagor CNC systems | News | CNCTimes.com
CNC BAND SAW MACHINE - SDJ 1200 | QUỐC DUY
CNC Router Operation : Woodworking Technology
CNC System Retrofit for Lathe with computer - Sherline Products
SolidCAM Car wheels CNC Machining 5 Axis | Videos | CNCTimes.com
Anti-PKA 2 beta (regulatory subunit) 抗体 [EP2649Y] (ab75993)
Carney complex - Wikipedia
CiNii Articles - Genetic Analysis in a Patient With Recurrent Cardiac Myxoma and Endocrinopathy
Assessment of cytologic evaluation of preputial epithelial cells as a diagnostic test for detection of adrenocortical disease...
obesity - BioMedLib™ search engine
obesity - BioMedLib™ search engine
Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors. | PubFacts
CNC Plastic Parts CNC Machining Product Made in China - China Machining, CNC Machining
China Customized 2D & 3D Rotary CNC Router Machine - China CNC Router, CNC Router Machine
Universal Type Wood CNC Router - 数控木工雕刻机 - Tenma Machine
China Bakelite/Phenol-Formaldehyde CNC Machining Part for Automation Machinery - China Phenol-Formaldehyde CNC Machining,...
Sargent Metal Fabrication - Supplier of bearings, bp, cnc lathes, cnc mills
China High Precise CNC Machined & Turned Parts-OEM Metal Parts - China Machining, CNC Machining
CNC Punching Design Tips
News | CNC Machine Tools | Gosiger | Hardinge
5 Consumables To Replace On A CNC Plasma Machine | MultiCam
CNC Manufacturing cells - Product - LIGNA 2017
STEMAC 315 CNC Plasma Cutting Machine: kúpiť použitý
Alice Sconce (is1096) | Remains.com
PRKAR1A
... sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase ... "A kinase anchoring protein (AKAP) interaction and dimerization of the RIalpha and RIbeta regulatory subunits of protein kinase ... Guild BC, Strominger JL (1984). "HLA-A2 antigen phosphorylation in vitro by cyclic AMP-dependent protein kinase. Sites of ... cAMP-dependent protein kinase type I-alpha regulatory subunit is an enzyme that in humans is encoded by the PRKAR1A gene. cAMP ...
Susan S. Taylor
... or cyclic AMP-dependent protein kinase. 1992: Elected to the American Academy of Arts and Sciences 1996: Elected to the ... RIalpha) subunits of PKA". Science. 307 (5710): 690-6. doi:10.1126/science.1104607. PMID 15692043. S2CID 32156686. Zhang, P; ... "Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase". Science. 253 (5018): ... She is known for her research on protein kinases, particularly protein kinase A. She was elected to the Institute of Medicine ...
A PKA inhibitor motif within SMOOTHENED controls Hedgehog signal transduction | Nature Structural & Molecular Biology
Here we show that SMO uses a decoy substrate sequence to physically block the active site of the cAMP-dependent protein kinase ... PKA) catalytic subunit (PKA-C) and extinguish its enzymatic activity. As a result, GLI is released from phosphorylation-induced ... which enables a G protein-coupled receptor to physically block the enzymatic activity of a major cellular kinase. ... our findings define a mode of GPCR-PKA communication that may be harnessed by a range of membrane receptors and kinases. Happ ...
SMART: RIIa domain annotation
Crystal structure of cAMP-dependent Protein Kinase A Regulatory Subunit I alpha in complex with dual-specific A-Kinase ... A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. ... Solution structure of the docking and dimerization domain of the type I alpha regulatory subunit of protein kinase A (RIalpha D ... Crystal structure of dual-specific A-kinase anchoring protein 2 in complex with cAMP-dependent protein kinase A type II alpha ...
Tokushima University / Educator and Researcher Directory --- Mizusawa, Noriko
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit / Cyclic AMP-Dependent Protein Kinases / Female / Gene Silencing / Growth ... PRKAR1A, which codes for the RIalpha regulatory subunit of cyclic AMP-dependent protein kinase A (PKA) on 17q23-24, was ... Adenoma / Aged / Carney Complex / Cyclic AMP-Dependent Protein Kinase RIalpha Subunit / Female / Gene Deletion / Germ-Line ... was to assess involvement of loss of the PRKAR1A gene encoding a type 1α regulatory subunit of cAMP-dependent protein kinase A ...
Craig Todd Basson, M.D.,Ph.D., M.D. | Harvard Catalyst Profiles | Harvard Catalyst
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit. *Cyclic AMP-Dependent Protein Kinases ...
PKA microdomain organisation and cAMP handling in healthy and dystrophic muscle in vivo. - Oxford Cardiovascular Science
To guarantee signal specificity, different PKA isoforms are compartmentalised by Akinase anchoring proteins (AKAPs) into ... functional relevance of such differential localisation was underscored by the finding of mutually exclusive and AKAP-dependent ... Signalling through protein kinase A (PKA) triggers a multitude of intracellular effects in response to a variety of ... Cyclic AMP, Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit, ...
Winnie Eskild
- Institutt for biovitenskap
Cyclic AMP increases the mRNA levels for the regulatory subunit (R-II51) of type II cAMP-dependent protein kinase in rat ... cyclic adenosine monophosphate-dependent protein kinases (RII beta and RI alpha) via multiple and distinct mechanisms. ... Hormonal regulation and age dependent changes in mRNA levels for regulatory subunits of cAMP-dependent protein kinases in rat ... Cellular localization and age-dependent changes in mRNA for cyclic adenosine 3',5'-monophosphate-dependent protein kinases in ...
Search
Sen. 1, subscore: 1.00 ]: Corn cob hydrolysates , with xylose as the dominant sugar , were fermented to ethanol by recombinant Escherichia coli KO11 . When inoculum was grown on LB medium containing glucose , fermentation of the hydrolysate was completed in 163 h and ethanol yield was 0 . 50 g ethanol/g sugar . When inoculum was grown on xylose , ethanol yield dropped , but fermentation was faster ( 113 h ) . Hydrolysate containing 72 . 0 g/l xylose and supplemented with 20 . 0 g/l rice bran was readily fermented , producing 36 . 0 g/l ethanol within 70 h . Maximum ethanol concentrations were not higher for fermentations using higher cellular concentration inocula . A simulation of an industrial process integrating pentose fermentation by E coli and hexose fermentation by yeast was carried out . At the first step , E coli fermented the hydrolysate containing 85 . 0 g/l xylose , producing 40 . 0 g/l ethanol in 94 h . Bakers yeast and sucrose ( 150 . 0 g/l ) were then added to the spent ...
DeCS
Cyclic AMP Dependent Protein Kinase RIalpha Subunit Cyclic-AMP-Dependent Protein Kinase RIalpha Subunit PKA RIalpha Protein ... Cyclic AMP Dependent Protein Kinase RIalpha Subunit. Cyclic-AMP-Dependent Protein Kinase RIalpha Subunit. PKA RIalpha. Protein ... Regulatory Subunit RIalpha, Cyclic AMP Dependent Protein Kinase Regulatory Subunit RIalpha, Cyclic-AMP-Dependent Protein Kinase ... RIalpha, PKA. RIalpha, Protein Kinase A. RIalpha, cAMP Protein Kinase. Regulatory Subunit RIalpha, Cyclic AMP Dependent Protein ...
Search | VHL CLAP/WR-PAHO/WHO
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit (4) * Immune Tolerance (4) * Biomarkers, Tumor (3) ... Heavily Pigmented Epithelioid Melanoma With Loss of Protein Kinase A Regulatory Subunit-α Expression. Cohen, Jarish N; Spies, ... Superficial Angiomyxomas Frequently Demonstrate Loss of Protein Kinase A Regulatory Subunit 1 Alpha Expression: ...
Tokushima University / Educator and Researcher Directory --- Mizusawa, Noriko
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit / Cyclic AMP-Dependent Protein Kinases / Female / Gene Silencing / Growth ... PRKAR1A, which codes for the RIalpha regulatory subunit of cyclic AMP-dependent protein kinase A (PKA) on 17q23-24, was ... Adenoma / Aged / Carney Complex / Cyclic AMP-Dependent Protein Kinase RIalpha Subunit / Female / Gene Deletion / Germ-Line ... was to assess involvement of loss of the PRKAR1A gene encoding a type 1α regulatory subunit of cAMP-dependent protein kinase A ...
PKA microdomain organisation and cAMP handling in healthy and dystrophic muscle in vivo. - Oxford Cardiovascular Science
To guarantee signal specificity, different PKA isoforms are compartmentalised by Akinase anchoring proteins (AKAPs) into ... functional relevance of such differential localisation was underscored by the finding of mutually exclusive and AKAP-dependent ... Signalling through protein kinase A (PKA) triggers a multitude of intracellular effects in response to a variety of ... Cyclic AMP, Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit, ...
Craig Todd Basson, M.D.,Ph.D., M.D. | Harvard Catalyst Profiles | Harvard Catalyst
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
SMART: RIIa domain annotation
Crystal structure of cAMP-dependent Protein Kinase A Regulatory Subunit I alpha in complex with dual-specific A-Kinase ... A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. ... Solution structure of the docking and dimerization domain of the type I alpha regulatory subunit of protein kinase A (RIalpha D ... Crystal structure of dual-specific A-kinase anchoring protein 2 in complex with cAMP-dependent protein kinase A type II alpha ...
A PKA inhibitor motif within SMOOTHENED controls Hedgehog signal transduction | Nature Structural & Molecular Biology
Here we show that SMO uses a decoy substrate sequence to physically block the active site of the cAMP-dependent protein kinase ... PKA) catalytic subunit (PKA-C) and extinguish its enzymatic activity. As a result, GLI is released from phosphorylation-induced ... which enables a G protein-coupled receptor to physically block the enzymatic activity of a major cellular kinase. ... our findings define a mode of GPCR-PKA communication that may be harnessed by a range of membrane receptors and kinases. Happ ...
Winnie Eskild - Institutt for biovitenskap
Cyclic AMP increases the mRNA levels for the regulatory subunit (R-II51) of type II cAMP-dependent protein kinase in rat ... cyclic adenosine monophosphate-dependent protein kinases (RII beta and RI alpha) via multiple and distinct mechanisms. ... Hormonal regulation and age dependent changes in mRNA levels for regulatory subunits of cAMP-dependent protein kinases in rat ... Cellular localization and age-dependent changes in mRNA for cyclic adenosine 3,5-monophosphate-dependent protein kinases in ...
Steroidogenic Factor-1 Lineage Origin of Skin Lesions in Carney Complex Syndrome - PubMed
... protein kinase A signaling pathway. Skin lesions are the most common manifestation of Carney complex, including … ... Cyclic AMP-Dependent Protein Kinase RIalpha Subunit / genetics Actions. * Search in PubMed ... protein kinase A signaling pathway. Skin lesions are the most common manifestation of Carney complex, including lentigines, ... under the influence of protein kinase A signaling, the production of promelanogenic EDN3 and hepatocyte GF signals. Our model ...
Biomarkers Search
MeSH Browser
Cyclic-AMP-Dependent Protein Kinase RIalpha Subunit Protein Kinase A, RIalpha Subunit RI alpha, cAMP Protein Kinase RIalpha, ... RIalpha, Protein Kinase A RIalpha, cAMP Protein Kinase Regulatory Subunit RIalpha, Cyclic-AMP-Dependent Protein Kinase Registry ... Cyclic AMP-Dependent Protein Kinase RIalpha Subunit [D12.776.476.563.150.125.750.625] * Cyclic AMP-Dependent Protein Kinase ... 2008; CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT was indexed under CYCLIC AMP-DEPENDENT PROTEIN KINASES 1998-2007. ...
MeSH Browser
Cyclic-AMP-Dependent Protein Kinase RIalpha Subunit Protein Kinase A, RIalpha Subunit RI alpha, cAMP Protein Kinase RIalpha, ... RIalpha, Protein Kinase A RIalpha, cAMP Protein Kinase Regulatory Subunit RIalpha, Cyclic-AMP-Dependent Protein Kinase Registry ... Cyclic AMP-Dependent Protein Kinase RIalpha Subunit [D12.776.476.563.150.125.750.625] * Cyclic AMP-Dependent Protein Kinase ... 2008; CYCLIC-AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT was indexed under CYCLIC AMP-DEPENDENT PROTEIN KINASES 1998-2007. ...
Alexandr Kornev | UCSD Profiles
RI{alpha}) subunits of cyclic AMP-dependent protein kinase. Mol Cell Proteomics. 2010 Oct; 9(10):2225-37. Anand GS, ... Dissecting the cAMP-inducible allosteric switch in protein kinase A RIalpha. Protein Sci. 2010 Jun; 19(6):1213-21. Sjoberg TJ, ... Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci. 2011 Feb; 36(2):65-77. Taylor SS, Kornev AP. ... Using Markov state models to develop a mechanistic understanding of protein kinase A regulatory subunit RIα activation in ...
NEW (2008) MESH HEADINGS WITH SCOPE NOTES (UNIT RECORD FORMAT; 11/05/2007
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Type II UI ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ... protein kinase A. HN - 2008(1998) BX - Protein Kinase A, RII beta Subunit MH - Cyclic AMP-Dependent Protein Kinase Type I UI - ...
NDF-RT Code NDF-RT Name
N0000178690 Cyclic AMP-Dependent Protein Kinase RIalpha Subunit N0000178691 Cyclic AMP-Dependent Protein Kinase RIbeta Subunit ... Subunit N0000178693 Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit N0000178794 Cyclic AMP-Dependent Protein Kinase Type I ... N0000178580 Cyclic AMP-Dependent Protein Kinase Type II N0000170598 Cyclic AMP-Dependent Protein Kinases N0000168775 Receptors ... Protein Kinase Type I N0000185712 Cyclic GMP-Dependent Protein Kinase Type II N0000170597 Cyclic GMP-Dependent Protein Kinases ...
Molecular features of product release for the PKA catalytic cycle - PubMed
Here we report the apo and ADP bound structures of the myristylated catalytic subunit of PKA at 2.9 and 3.5 Å resolution, ... Although ADP release is the rate limiting step in product turnover by protein kinase A, the steps and motions involved in this ... Cyclic AMP-Dependent Protein Kinases / chemistry* Actions. * Search in PubMed * Search in MeSH ... Dynamic binding of PKA regulatory subunit RI alpha. Gullingsrud J, Kim C, Taylor SS, McCammon JA. Gullingsrud J, et al. ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
KINASE RIBETA SUBUNIT. HN - 2008(1998) BX - Protein Kinase A, RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinase RIbeta ... Protein Kinase A, Type I BX - Protein Kinase Type I, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase Catalytic ... Protein Kinase A, Type II BX - Protein Kinase Type II, Cyclic AMP-Dependent MH - Cyclic AMP-Dependent Protein Kinase RIIalpha ... HN - 2008 BX - Protein Kinase A, Catalytic Subunits MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit UI - D054756 MN - ...
S-EPMC2794773 - Structural insights into the mechanism of the allosteric transitions of Mycobacterium tuberculosis cAMP...
As a result, the entire N-domain and the C-domain of subunit B integrated by the cAMP portion of this ligand, together tilt ... responsible for the regulation of a multitude of diverse proteins. We have determined the crystal structures of the CRP.cAMP ... However, the bulkier N6 extension of N(6)-cAMP (in R conformation) is accommodated only in subunit A with minor changes, ... whereas in subunit B, the N6 extension is in the S conformation hindering the hinge region of the central helix. ...
VCell Published Models - VCell- Modeling & Analysis Software
Using Markov state models to develop a mechanistic understanding of protein kinase A regulatory subunit RIalpha activation in ... A predictive computational model reveals that giv/girdin serves as a tunable valve for egfr-stimulated cyclic amp signals.. ... Whole-Cell Photobleaching Reveals Time-Dependent Compartmentalization of Soluble Proteins by the Axon Initial Segment.. ... Contributions of protein kinases and beta-arrestin to termination of protease-activated receptor 2 signaling. Jung, S. R., Seo ...
and
... protein time point with acid nos oral other quantitative concentration for gene product left antibody right tablet serum ... fire foley metal leukocytes challenge deformity ile bromo valyl plant ureter coated tests diabetes action cyclic encourage ... length normal pulmonary breast therapy abdominal vertebral name peptide collision membrane limb enzyme partial potassium kinase ... communication conditions fibrinogen genetics notch phase latex tar descending forte mdl data herpesvirus communicating foam amp ...
CAMP-depend4
- A type I cAMP-dependent protein kinase regulatory subunit that plays a role in confering CYCLIC AMP activation of protein kinase activity. (bvsalud.org)
- The adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase (PKA) is localized through interaction of the regulatory (R) subunit dimer with A-kinase-anchoring proteins (AKAPs). (embl.de)
- P. Banky, L. Huang, and S. S. Taylor , Dimerization/docking domain of the type Ia regulatory subunit of cAMP-dependent protein kinase. (inserm.fr)
- Here we show that SMO uses a decoy substrate sequence to physically block the active site of the cAMP-dependent protein kinase (PKA) catalytic subunit (PKA-C) and extinguish its enzymatic activity. (nature.com)
AKAPs2
Specificity1
- Dual specificity protein kinases (e.g. (embl.de)
Holoenzyme1
- In addition to its role as an inhibitor of the C subunit, the R subunit anchors the holoenzyme to specific intracellular locations and prevents the C subunit from entering the nucleus. (embl.de)
Inhibitors1
- Pituitary adenomas: role of cyclin-dependent kinase inhibitors, Springer, Oct. 2013. (tokushima-u.ac.jp)
Serine1
- Identification of protease serine S1 family member 53 as a mitochondrial protein in murine islet beta cells, Islets, Vol.14, No.1, 1-13, 2021. (tokushima-u.ac.jp)
Intracellular1
- Signalling through protein kinase A (PKA) triggers a multitude of intracellular effects in response to a variety of extracellular stimuli. (ox.ac.uk)
AKAP3
- The functional relevance of such differential localisation was underscored by the finding of mutually exclusive and AKAP-dependent increases in [cAMP] in the PKA type I and PKA type II microdomains upon application of different cAMP agonists. (ox.ac.uk)
- We now report the solution structure of the type II PKA R-subunit fragment RIIalpha(1-44), which encompasses both the AKAP-binding and dimerization interfaces. (embl.de)
- NMR data on the complex between RIIalpha(1-44) and an AKAP fragment reveals extensive contacts between the two proteins. (embl.de)
Amino1
- Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. (embl.de)
Functional1
- Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. (embl.de)
Role1
- Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. (embl.de)
Revealed by solution1
- The molecular basis for protein kinase A anchoring revealed by solution NMR. (embl.de)
Activation2
- In conclusion, DDT transcription may be regulated in a cell-dependent manner, and were enhanced by AMPK activation in SGBS adipocytes through inhibiting the mTOR signaling. (tokushima-u.ac.jp)
- A pivotal step in Hh signal transduction is the activation of glioma-associated (GLI) transcription factors by the atypical G protein-coupled receptor (GPCR) SMOOTHENED (SMO). (nature.com)
Domains1
- There are 1650 RIIa domains in 1614 proteins in SMART's nrdb database. (embl.de)
Formation1
- Formation of these complexes is mediated by specialized protein motifs that participate in protein-protein interactions. (embl.de)
Development2
- Hui, C. C. & Angers, S. Gli proteins in development and disease. (nature.com)
- Age-dependent development of liver fibrosis in Glmp (gt/gt) mice. (uio.no)
Regulatory5
- A type I cAMP-dependent protein kinase regulatory subunit that plays a role in confering CYCLIC AMP activation of protein kinase activity. (nih.gov)
- Over fifty members of this family exist, most of which bind specifically to regulatory subunits of CYCLIC-AMP-DEPENDENT PROTEIN KINASE TYPE II such as CAMP PROTEIN KINASE RIIALPHA or CAMP PROTEIN KINASE RIIBETA. (nih.gov)
- Molecular Simulations Reveal an Unresolved Conformation of the Type IA Protein Kinase A Regulatory Subunit and Suggest Its Role in the cAMP Regulatory Mechanism. (omicsdi.org)
- We identify a previously unresolved, unrecognized, and highly stable conformation of the protein kinase A (PKA) regulatory subunit RI? (omicsdi.org)
- Isoleucine 368 is involved in low-affinity binding of N6-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I. (omicsdi.org)
Conformation3
- Corrigendum to "A Catalytically-Disabled Double Mutant of Src Tyrosine Kinase Can Be Stabilized into an Active-Like Conformation. (ucsd.edu)
- However, the bulkier N6 extension of N(6)-cAMP (in R conformation) is accommodated only in subunit A with minor changes, whereas in subunit B, the N6 extension is in the S conformation hindering the hinge region of the central helix. (omicsdi.org)
- Brownian dynamics simulations suggest that the Flipback conformation plays a role in cAMP association to the A domain of the R subunit. (omicsdi.org)
Regulation2
- Disordered Protein Kinase Regions in Regulation of Kinase Domain Cores. (ucsd.edu)
- The cAMP receptor protein (CRP) from Mycobacterium tuberculosis is a cAMP-responsive global transcriptional regulator, responsible for the regulation of a multitude of diverse proteins. (omicsdi.org)
CAMP5
- Carney complex is a rare familial multineoplastic syndrome predisposing to endocrine and nonendocrine tumors due to inactivating mutations of PRKAR1A, leading to perturbations of the cAMP‒protein kinase A signaling pathway. (nih.gov)
- Structural insights into the mechanism of the allosteric transitions of Mycobacterium tuberculosis cAMP receptor protein. (omicsdi.org)
- Based on the CRP.N(6)-cAMP crystal structure, binding of N(6)-cAMP with a bulkier methylphenylethyl extension from the N6 atom stabilizes the cAMP-binding domain, N-domain hairpin, and C-terminal domain in a similar manner as that of the CRP.cAMP structure, maintaining structural integrity within the subunits. (omicsdi.org)
- As a result, the entire N-domain and the C-domain of subunit B integrated by the cAMP portion of this ligand, together tilt away ( approximately 7 degrees tilt) from central helix C, positioning the helix-turn-helix motif in an unfavorable position for the DNA substrate, asymmetrically. (omicsdi.org)
- Epac2 is a member of the family of exchange proteins directly activated by cAMP (Epac). (omicsdi.org)
Alpha1
- HN - 2008 (1997) MH - Alpha-Amanitin UI - D053959 MN - D4.345.566.50.111 MN - D12.644.456.50.111 MN - D12.644.641.50.111 MN - D23.946.587.175.111 MS - A cyclic octapeptide with a thioether bridge between the cystine and tryptophan. (nih.gov)
Domain2
Activity1
- HN - 2008 (1993) MH - Agouti-Related Protein UI - D054369 MN - D12.644.276.74 MN - D12.776.467.74 MN - D23.529.74 MS - A secreted protein of approximately 131 amino acids that is related to AGOUTI SIGNALING PROTEIN and is also an antagonist of MELANOCORTIN RECEPTOR activity. (nih.gov)
Structure2
Family1
- 11/05/2007) TOTAL 2008 NEW DESCRIPTORS = 456 MH - A Kinase Anchor Proteins UI - D054758 MN - D12.644.360.24.65 MN - D12.776.157.57.01 MN - D12.776.476.24.69 MS - A structurally-diverse family of intracellular-signaling adaptor proteins that selectively tether specific protein kinase A subtypes to distinct subcellular sites. (nih.gov)